NASDAQ:APLT
Delisted

Applied Therapeutics Stock Predictions

etoro logo Buy APLT
*Your capital is at risk
$0.0959
+0 (+0%)
At Close: Apr 28, 2026
Currently predicting for Fri, 5 Jun 2026

APLT Prediction Chart

APLT Predictions History

Latest community submissions for APLT.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 18, 2025 $0.606 -6.40% $0.589 V 97.25% 1
Feb 18, 2025 $0.621 -4.00% $0.589 V 94.62% 1
Feb 18, 2025 Bullish $0.589 X 0
Feb 7, 2025 $0.562 -7.72% $0.610 X 92.14% 0
Feb 7, 2025 $0.580 -4.82% $0.610 X 95.04% 0
Feb 7, 2025 Bullish $0.610 V 1
Jan 14, 2025 $0.790 +14.33% $0.640 X 76.52% 0
Jan 14, 2025 $0.753 +8.96% $0.640 X 82.32% 0
Jan 14, 2025 Bearish $0.640 V 1
Dec 30, 2024 $1.01 +18.16% $0.82 X 76.29% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for APLT with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT APPLIED THERAPEUTICS INC.
Applied Therapeutics
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE